| Income Statement |
| Total Revenue | 720.84M |
|
| Revenues (USD) | 720.84M |
| Cost of Revenue | 559.93M |
| Gross Profit | 160.91M |
| Operating Expenses | 128.01M |
| Research and Development Expense | 43.78M |
| Selling, General and Administrative Expense | 84.24M |
| Operating Income | 32.90M |
| Income Tax Expense | -1.15M |
| Net Income | 11.67M |
| Net Income Common Stock | 11.67M |
| Net Income Common Stock (USD) | 11.67M |
| Consolidated Income | 55.00M |
| Net Income to Non-Controlling Interests | 43.33M |
| Earnings per Basic Share | 0.09 |
| Earnings per Basic Share (USD) | 0.09 |
| Earnings per Diluted Share | 0.09 |
| Earning Before Interest & Taxes (EBIT) | 10.52M |
| Earning Before Interest & Taxes (USD) | 10.52M |
| Weighted Average Shares | 128.08M |
| Weighted Average Shares Diluted | 133.25M |
| Balance Sheet |
| Cash and Equivalents | 1.75B |
| Cash and Equivalents (USD) | 1.75B |
| Investments | 140.47M |
| Investments Non-Current | 140.47M |
| Trade and Non-Trade Receivables | 748.38M |
| Current Assets | 2.86B |
| Property, Plant & Equipment Net | 158.57M |
| Total Assets | 3.52B |
| Current Liabilities | 2.15B |
| Total Liabilities | 2.39B |
| Accumulated Retained Earnings (Deficit) | -1.32B |
| Accumulated Other Comprehensive Income | -2.73M |
| Shareholders Equity | 708.77M |
| Shareholders Equity (USD) | 708.77M |
| Assets Non-Current | 666.33M |
| Deferred Revenue | 1.74B |
| Goodwill and Intangible Assets | 143.12M |
| Inventory | 220.84M |
| Liabilities Non-Current | 243.08M |
| Trade and Non-Trade Payables | 327.81M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 10.25M |
| Net Cash Flow from Financing | 14.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -238.07M |
| Capital Expenditure | -17.33M |
| Net Cash Flow - Business Acquisitions and Disposals | -73.42M |
| Net Cash Flow from Investing | -90.75M |
| Net Cash Flow from Operations | -147.30M |
| Effect of Exchange Rate Changes on Cash | -31.00K |
| Share Based Compensation | 48.43M |